Drugs / KD018
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02178644 | Jul 2014 → Sep 2019 | rectal cancer | Yale University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00730158 | Dec 2008 → Jun 2016 | colorectal cancer | Edward Chu, MD | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KD018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02178644 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Traditional Chinese Medicine formulation administered orally” NCT00730158 ↗ |
| Route | Oral | “administered orally” NCT00730158 ↗ |